Article
An In-Depth Evaluation of the Validity and Logistics Surrounding the Testing of AR-V7 mRNA Expression in Circulating Tumor Cells.
The Journal of molecular diagnostics : JMD - 1 May 2018
Sieuwerts Anieta M, Mostert Bianca, van der Vlugt-Daane Michelle, Kraan Jaco, Beaufort Corine M, Van Mai, Prager Wendy J C, De Laere Bram, Beije Nick, Hamberg Paul, Westgeest Hans M, Tascilar Metin, Dirix Luc Y, Onstenk Wendy, de Wit Ronald, Lolkema Martijn P, Mathijssen Ron H J, Martens John W M, Sleijfer Stefan
Abstract excerpt
Recent reports have emphasized the clinical relevance of detecting AR-V7 in circulating tumor cells (CTCs). Our aim was to set up a validated multicenter pipeline to measure AR-V7 by quantitative RT-PCR (RT-qPCR) in RNA isolated from CellSearch-enriched CTCs to provide an AR-V7-positive or AR-V7-negative score in a clinically acceptable time range. CellSearch-enirched CTCs from patients with metastatic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
